The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases

• Status: Recruiting
• Trial end date: 2022-06-24
• Target enrollment: 0
• Participant gender: Female

Summary

Investigation of the influence of combined oral contraception on the development and progression of chronic venous diseases

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia
• Treatments: Contraceptive Agents; Contraceptives, Oral; Contraceptives, Oral, Combined

Criteria

Inclusion Criteria:

1. The investigators consistently include patients who have been prescribed hormonal tablets for contraception, namely 1) COCs with bioidentical estrogen; 2) COCs with ethinyl estradiol 30mkg according to the scheme 21 + 7; 3) COCs with ethinyl estradiol 20mkg according to the scheme 21 + 7.

2. Clinical class C0-1 according to CEAP;

2) Able to come for checkups every 3 months; 3) The presence of informed consent.

Exclusion Criteria:

1. Age up to 45 years;

2. A history of surgical treatment of veins of the lower extremities;

3. Clinical class C2 and higher according to CEAP;

4. History of DVT or PE;

5. Aplasia or angio-dysplasia of deep veins;

6. Restriction of mobility;

7. Arterial insufficiency;

8. Oncological diseases.